These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34873491)

  • 1. Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple negative breast cancer (TNBC).
    Tokumaru Y; Oshi M; Murthy V; Tian W; Yan L; Angarita FA; Nagahashi M; Matsuhashi N; Futamura M; Yoshida K; Miyoshi Y; Takabe K
    Am J Cancer Res; 2021; 11(11):5743-5755. PubMed ID: 34873491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
    Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
    Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer.
    Chae S; Kang KM; Kim HJ; Kang E; Park SY; Kim JH; Kim SH; Kim SW; Kim EK
    Curr Oncol; 2018 Apr; 25(2):e113-e119. PubMed ID: 29719435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple-Negative Subtype of Breast Cancer Patients.
    Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
    J Immunol Res; 2020; 2020():5618786. PubMed ID: 33457427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer.
    Asano Y; Kashiwagi S; Onoda N; Noda S; Kawajiri H; Takashima T; Ohsawa M; Kitagawa S; Hirakawa K
    Ann Surg Oncol; 2016 Apr; 23(4):1104-10. PubMed ID: 26511266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serum NLR, PLR and HALP with efficacy of neoadjuvant chemotherapy and prognosis of triple-negative breast cancer.
    Lou C; Jin F; Zhao Q; Qi H
    Am J Transl Res; 2022; 14(5):3240-3246. PubMed ID: 35702128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC3F expression in triple-negative breast cancer is associated with tumor microenvironment infiltration and activation of cancer immunity and improved survival.
    Wu R; Oshi M; Asaoka M; Huyser MR; Tokumaru Y; Yamada A; Yan L; Endo I; Ishikawa T; Takabe K
    Am J Cancer Res; 2022; 12(2):744-762. PubMed ID: 35261799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation.
    Tokumaru Y; Oshi M; Katsuta E; Yan L; Huang JL; Nagahashi M; Matsuhashi N; Futamura M; Yoshida K; Takabe K
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Intratumoral Interrelation among FOXP3+ Regulatory T Cells on Treatment Response and Survival in Triple-Negative Breast Cancer.
    Goda N; Nakashima C; Nagamine I; Otagaki S
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Usefulness of the Pretreatment Neutrophil/Lymphocyte Ratio as a Predictor of the 5-Year Survival in Stage 1-3 Triple Negative Breast Cancer Patients.
    Azab B; Amundson JR; Cioci A; Stuart H; Yakoub D; Avisar E; Moffat F; Livingstone AS; Franceschi D
    Breast Care (Basel); 2021 Feb; 16(1):43-49. PubMed ID: 33716631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
    Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
    PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of the preoperative albumin to globulin ratio and neutrophil to lymphocyte ratio as a novel prognostic factor in patients with triple negative breast cancer.
    Xuan Q; Yang Y; Ji H; Tang S; Zhao J; Shao J; Wang J
    Cancer Manag Res; 2019; 11():5125-5131. PubMed ID: 31213922
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic Roles of Neutrophil-to-Lymphocyte Ratio and Stromal Tumor-Infiltrating Lymphocytes and Their Relationship in Locally Advanced Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Dong X; Liu C; Yuan J; Wang S; Ding N; Li Y; Wu Y; Xiao Z
    Breast Care (Basel); 2021 Aug; 16(4):328-334. PubMed ID: 34602938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
    Patel DA; Xi J; Luo J; Hassan B; Thomas S; Ma CX; Campian JL
    Breast Cancer Res Treat; 2019 Apr; 174(2):443-452. PubMed ID: 30604000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC).
    Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Kalinski P; Endo I; Takabe K
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33198125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Three-Gene Score as a Predictive Biomarker for Pathologically Complete Response after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
    Oshi M; Angarita FA; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased neutrophil-lymphocyte ratio independently predicts poor survival in non-metastatic triple-negative breast cancer patients.
    Qiu X; Song Y; Cui Y; Liu Y
    IUBMB Life; 2018 Jun; 70(6):529-535. PubMed ID: 29707892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival.
    Oshi M; Tokumaru Y; Angarita FA; Lee L; Yan L; Matsuyama R; Endo I; Takabe K
    Sci Rep; 2021 Jun; 11(1):12541. PubMed ID: 34131208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer.
    Ning L; Xie N
    Cancer Manag Res; 2024; 16():137-150. PubMed ID: 38476973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-Sequencing of the Neutrophil-to-Lymphocyte Ratio to Predict Prognosis of Triple-Negative Breast Cancer.
    Kim JH; Son NH; Lee JS; Mun JE; Kim JY; Park HS; Park S; Kim SI; Park BW
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.